FDA approves human trial for speech-restoring brain chip

newatlas.com

The FDA has approved a human trial for a brain chip designed to restore speech in paralyzed individuals. Paradromics' Connexus BCI, a fully implantable device with over 400 electrodes, will be tested for safety and efficacy in helping patients communicate via text or synthesized voice. This trial marks a significant step for brain-computer interfaces, with potential to expand to more participants if initial results are positive.


With a significance score of 5.6, this news ranks in the top 0.7% of today's 29749 analyzed articles.

Get summaries of news with significance over 5.5 (usually ~10 stories per week). Read by 10,000+ subscribers: